SENATE-BILL 3349: S.3349 - PBM Disclosure Act
AI-Powered Summary
SENATE-BILL 3349 aims to enhance transparency in employer-sponsored health plans by requiring clearer disclosures regarding compensation from pharmacy benefit managers (PBMs) and third-party administrators. The legislation addresses major themes of healthcare cost transparency and the regulation of financial dealings within health plans, impacting individuals' access to information that could influence their healthcare choices. Key provisions include the requirement for the Secretary of Labor to establish regulations within 180 days of enactment to ensure these disclosures are made, thereby potentially reducing healthcare costs for individuals. The bill emphasizes that it does not impose additional requirements beyond existing laws, which may mitigate concerns about increased regulatory burdens on service providers. The implementation timeline is set for 180 days post-enactment, and the potential impacts include improved transparency that could lead to better-informed healthcare decisions for individuals, while also raising constitutional concerns about federal authority and the adequacy of public input in the regulatory process.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The PBM Disclosure Act has significant implications for individual rights, particularly in enhancing consumer empowerment and promoting transparency in healthcare. By mandating the disclosure of compensation practices, the bill aims to protect individuals from potential exploitation and ensure equitable access to necessary medications.
Key Individual Rights Affected
- Right to Information
- Equal Protection
- Due Process
Constitutional Provisions
- First Amendment (Right to Information)
- Fourteenth Amendment (Equal Protection Clause)
- Fifth Amendment (Due Process)
Potential Constitutional Challenges
While the bill supports transparency, there may be challenges regarding its implementation, particularly if it fails to address disparities in access to information among different demographic groups. This could lead to claims of unequal protection under the law, especially for marginalized communities.
Summary
The PBM Disclosure Act seeks to enhance transparency in pharmacy benefit management, which can empower individuals to make informed healthcare decisions. Its constitutional implications are largely positive, supporting the rights to information and equal protection. However, careful monitoring is necessary to ensure that all demographic groups benefit equally from the disclosures mandated by the bill, thereby upholding constitutional protections for all individuals.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention S. 3349 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
December 4, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat